聚合物工程 PROTAC 纳米车辆通过 BRD4 降解来扩大与泰莫索洛米德的协同效应
Yun Guo1, Haoyu You1, Yiyang Li1
1School of Pharmacy, Minhang Hospital, Key Laboratory of Smart Drug Delivery/Innovative Center for New Drug Development of Immune Inflammatory Diseases (Ministry of Education), State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Department of Pharmaceutics, Fudan University, Shanghai 201203, China. sunt@fudan.edu.cn.
Biomaterials science
|July 29, 2025
概括
纳米颗粒通过增强溶解性和生物可用性来改善质母细胞瘤 (GBM) 治疗的蛋白质分解向嵌合体 (PROTACs). 这种方法显示了与化疗的协同作用,为新的GBM治疗铺平了道路.
科学领域:
- 在瘤学瘤学.
- 纳米技术纳米技术
- 生物化学 生物化学
背景情况:
- 质母细胞瘤 (GBM) 是一种具有有限治疗选择的侵袭性脑瘤.
- 化向化体 (PROTACs) 通过降解BRD4.4等向蛋白质,提供了一种新的治疗策略.
- 目前PROTAC的局限性包括溶解性,稳定性和生物利用性差,阻碍了临床使用.
研究的目的:
- 为了评估纳米粒子配方 (PLGA,PCL,多氨基酸) 优化ARV-825,一个BRD4降解的PROTAC.
- 研究纳米粒子特性和PROTAC结构对疗效和毒性的影响.
- 在GBM中评估PROTAC装载纳米颗粒与temozolomide (TMZ) 的协同抗瘤效应.
主要方法:
- 对纳米粒子配方的系统评估,包括PLGA,PCL和基于多氨基酸的载体.
- 纳米粒子的粒子大小,多分散度指数 (PDI) 和封装效率的表征.
- 循环载体的计算机模拟设计和PROTAC分子结构和毒性作用时间的评估.
主要成果:
- 为BRD4降解的PROTAC ARV-825开发了优化的纳米粒子配方.
- 与免费的PROTAC相比,ARV-825的纳米粒子输送显示出更好的特性.
- 同时提供ARV-825纳米粒子与temozolomide (TMZ) 导致GBM细胞中的协同抗瘤效应.
结论:
- 纳米粒子有效地解决了PROTACs的局限性,增强了它们对GBM的治疗潜力.
- 这种纳米交付策略为将PROTAC技术转化为针对脑瘤的临床应用提供了可行的途径.
- 这些发现支持开发先进的纳米药物来挑战质母细胞瘤等癌症.
相关概念视频
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
01:15Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
01:27Tumor Immunotherapy
662
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
662